Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


OLIENA
Language recovery after stroke
App | Video | PDF (278 pp) | Web

  Peptic Ulcer

  Free Subscription


Articles published in Helicobacter

Retrieve available abstracts of 179 articles:
HTML format
Text format



Single Articles


    April 2019
  1. BAYLINA M, Munoz N, Sanchez-Delgado J, Lopez-Gongora S, et al
    Systematic review: Would susceptibility-guided treatment achieve acceptable cure rates for second-line Helicobacter pylori therapy as currently practiced?
    Helicobacter. 2019 Apr 16:e12584. doi: 10.1111/hel.12584.
    PubMed     Text format     Abstract available


  2. KUO HY, Chang WL, Yeh YC, Cheng HC, et al
    Spasmolytic polypeptide-expressing metaplasia associated with higher expressions of miR-21, 155, and 223 can be regressed by Helicobacter pylori eradication in the gastric cancer familial relatives.
    Helicobacter. 2019 Apr 16:e12578. doi: 10.1111/hel.12578.
    PubMed     Text format     Abstract available


  3. KWON YH, Jeon SW, Nam SY, Lee HS, et al
    Efficacy of tailored therapy for Helicobacter pylori eradication based on clarithromycin resistance and survey of previous antibiotic exposure: A single-center prospective pilot study.
    Helicobacter. 2019 Apr 10:e12585. doi: 10.1111/hel.12585.
    PubMed     Text format     Abstract available


  4. POLYZOS SA, Kountouras J
    Helicobacter pylori infection and nonalcoholic fatty liver disease: Time for large clinical trials evaluating eradication therapy.
    Helicobacter. 2019 Apr 5:e12588. doi: 10.1111/hel.12588.
    PubMed     Text format    


  5. LAREDO V, Sostres C, Alfaro E, Arroyo MT, et al
    Management of Helicobacter pylori infection at the primary care level. The implementation of specific counseling improves eradication rates.
    Helicobacter. 2019 Apr 5:e12586. doi: 10.1111/hel.12586.
    PubMed     Text format     Abstract available


  6. UOTANI T, Murakami K, Uchida T, Tanaka S, et al
    Changes of tight junction and interleukin-8 expression using a human gastroid monolayer model of Helicobacter pylori infection.
    Helicobacter. 2019 Apr 5:e12583. doi: 10.1111/hel.12583.
    PubMed     Text format     Abstract available


  7. PENG C, Li NS, Hu Y, Lu NH, et al
    Impact factors that modulate gastric cancer risk in Helicobacter pylori-infected rodent models.
    Helicobacter. 2019 Apr 4:e12580. doi: 10.1111/hel.12580.
    PubMed     Text format     Abstract available


  8. YAN W, Gu L, Ren W, Ma X, et al
    Recognition of Helicobacter pylori by protein-targeting aptamers.
    Helicobacter. 2019 Apr 4:e12577. doi: 10.1111/hel.12577.
    PubMed     Text format     Abstract available


  9. VESGA FJ, Moreno Y, Ferrus MA, Ledesma-Gaitan LM, et al
    Correlation among fecal indicator bacteria and physicochemical parameters with the presence of Helicobacter pylori DNA in raw and drinking water from Bogota, Colombia.
    Helicobacter. 2019 Apr 4:e12582. doi: 10.1111/hel.12582.
    PubMed     Text format     Abstract available


  10. GUVEN B, Gulerman F, Kacmaz B
    Helicobacter pylori resistance to clarithromycin and fluoroquinolones in a pediatric population in Turkey: A cross-sectional study.
    Helicobacter. 2019 Apr 4:e12581. doi: 10.1111/hel.12581.
    PubMed     Text format     Abstract available


    March 2019
  11. ZHOU BG, Yang HJ, Xu W, Wang K, et al
    Association between Helicobacter pylori infection and nonalcoholic fatty liver disease: A systematic review and meta-analysis of observational studies.
    Helicobacter. 2019 Mar 25:e12576. doi: 10.1111/hel.12576.
    PubMed     Text format     Abstract available


  12. SOUZA MJ, de Moraes JA, Da Silva VN, Helal-Neto E, et al
    Helicobacter pylori urease induces pro-inflammatory effects and differentiation of human endothelial cells: Cellular and molecular mechanism.
    Helicobacter. 2019 Mar 25:e12573. doi: 10.1111/hel.12573.
    PubMed     Text format     Abstract available


  13. OKUDA M, Lin Y, Wang C, Kakiuchi T, et al
    Metronidazole for Helicobacter pylori eradication therapy among children and adolescents in Japan: Overcoming controversies and concerns.
    Helicobacter. 2019 Mar 15:e12575. doi: 10.1111/hel.12575.
    PubMed     Text format     Abstract available


  14. AREVALO GALVIS A, Trespalacios Rangel AA, Otero Regino W
    Personalized therapy for Helicobacter pylori: CYP2C19 genotype effect on first-line triple therapy.
    Helicobacter. 2019 Mar 11:e12574. doi: 10.1111/hel.12574.
    PubMed     Text format     Abstract available


  15. WANG T, Yang X, Li Y, Li L, et al
    Twice daily short-message-based re-education could improve Helicobacter pylori eradication rate in young population: A prospective randomized controlled study.
    Helicobacter. 2019 Mar 8:e12569. doi: 10.1111/hel.12569.
    PubMed     Text format     Abstract available


    February 2019
  16. HSIEH MS, Liu CJ, Hsu WH, Li CJ, et al
    Gastric juice-based PCR assay: An alternative testing method to aid in the management of previously treated Helicobacter pylori infection.
    Helicobacter. 2019 Feb 28:e12568. doi: 10.1111/hel.12568.
    PubMed     Text format     Abstract available


  17. LU B, Wang J, Li J, Liu L, et al
    Half-dose clarithromycin-containing bismuth quadruple therapy is effective and economical in treating Helicobacter pylori infection: A single-center, open-label, randomized trial.
    Helicobacter. 2019 Feb 19:e12566. doi: 10.1111/hel.12566.
    PubMed     Text format     Abstract available


  18. NYSSEN OP, McNicholl AG, Gisbert JP
    Meta-analysis of three-in-one single capsule bismuth-containing quadruple therapy for the eradication of Helicobacter pylori.
    Helicobacter. 2019 Feb 14:e12570. doi: 10.1111/hel.12570.
    PubMed     Text format     Abstract available


  19. ZHAO Y, Gao X, Guo J, Yu D, et al
    Helicobacter pylori infection alters gastric and tongue coating microbial communities.
    Helicobacter. 2019 Feb 7:e12567. doi: 10.1111/hel.12567.
    PubMed     Text format     Abstract available


    January 2019
  20. KO SW, Kim YJ, Chung WC, Lee SJ, et al
    Bismuth supplements as the first-line regimen for Helicobacter pylori eradication therapy: Systemic review and meta-analysis.
    Helicobacter. 2019 Jan 30:e12565. doi: 10.1111/hel.12565.
    PubMed     Text format     Abstract available


  21. CHEN Q, Liang X, Long X, Yu L, et al
    Cost-effectiveness analysis of screen-and-treat strategy in asymptomatic Chinese for preventing Helicobacter pylori-associated diseases.
    Helicobacter. 2019 Jan 22:e12563. doi: 10.1111/hel.12563.
    PubMed     Text format     Abstract available


  22. ZHAN Y, Si M, Li M, Jiang Y, et al
    The risk of Helicobacter pylori infection for adverse pregnancy outcomes: A systematic review and meta-analysis.
    Helicobacter. 2019 Jan 22:e12562. doi: 10.1111/hel.12562.
    PubMed     Text format     Abstract available


  23. LEE JW, Kim N, Nam RH, Lee SM, et al
    Favorable outcomes of culture-based Helicobacter pylori eradication therapy in a region with high antimicrobial resistance.
    Helicobacter. 2019 Jan 10:e12561. doi: 10.1111/hel.12561.
    PubMed     Text format     Abstract available


    December 2018
  24. HAYS C, Delerue T, Lamarque D, Burucoa C, et al
    Molecular diagnosis of Helicobacter pylori infection in gastric biopsies: Evaluation of the Amplidiag((R)) H. pylori + ClariR assay.
    Helicobacter. 2018 Dec 12:e12560. doi: 10.1111/hel.12560.
    PubMed     Text format     Abstract available


  25. HONMA H, Nakayama Y, Kato S, Hidaka N, et al
    Clinical features of Helicobacter pylori antibody-positive junior high school students in Nagano Prefecture, Japan.
    Helicobacter. 2018 Dec 4:e12559. doi: 10.1111/hel.12559.
    PubMed     Text format     Abstract available


    November 2018
  26. COSME A, Torrente Iranzo S, Montes Ros M, Fernandez-Reyes Silvestre M, et al
    Helicobacter pylori antimicrobial resistance during a 5-year period (2013-2017) in northern Spain and its relationship with the eradication therapies.
    Helicobacter. 2018 Nov 20:e12557. doi: 10.1111/hel.12557.
    PubMed     Text format     Abstract available


  27. NESHANI A, Zare H, Akbari Eidgahi MR, Hooshyar Chichaklu A, et al
    Review of antimicrobial peptides with anti-Helicobacter pylori activity.
    Helicobacter. 2018 Nov 15:e12555. doi: 10.1111/hel.12555.
    PubMed     Text format     Abstract available


  28. ANBARI F, Ashouri Moghaddam A, Sabeti E, Khodabakhshi A, et al
    Halitosis: Helicobacter pylori or oral factors.
    Helicobacter. 2018 Nov 15:e12556. doi: 10.1111/hel.12556.
    PubMed     Text format     Abstract available


  29. GRAHAM DY, Lu H, Dore MP
    Relative potency of proton-pump inhibitors, Helicobacter pylori therapy cure rates, and meaning of double-dose PPI.
    Helicobacter. 2018 Nov 15:e12554. doi: 10.1111/hel.12554.
    PubMed     Text format     Abstract available


  30. SZAFLARSKA-POPLAWSKA A, Soroczynska-Wrzyszcz A
    Prevalence of Helicobacter pylori infection among junior high school students in Grudziadz, Poland.
    Helicobacter. 2018 Nov 15:e12552. doi: 10.1111/hel.12552.
    PubMed     Text format     Abstract available


  31. SHINDLER-ITSKOVITCH T, Chodick G, Shalev V, Muhsen K, et al
    Helicobacter pylori infection and prevalence of stroke.
    Helicobacter. 2018 Nov 15:e12553. doi: 10.1111/hel.12553.
    PubMed     Text format     Abstract available


  32. SIA R, Plouzeau C, Godonou HSM, Guingane A, et al
    Low-level primary clarithromycin resistance of Helicobacter pylori in Burkina Faso: A prospective molecular study.
    Helicobacter. 2018 Nov 12:e12551. doi: 10.1111/hel.12551.
    PubMed     Text format    


  33. PONZETTO A, Holton J
    Extragastric diseases correlated with Helicobacter pylori.
    Helicobacter. 2018 Nov 9:e12549. doi: 10.1111/hel.12549.
    PubMed     Text format    


  34. WU YY, Hsieh CT, Tsay GJ, Kao JT, et al
    Recruitment of CCR6(+ ) Foxp3(+) regulatory gastric infiltrating lymphocytes in Helicobacter pylori gastritis.
    Helicobacter. 2018 Nov 9:e12550. doi: 10.1111/hel.12550.
    PubMed     Text format     Abstract available


    October 2018
  35. MACIAS-GARCIA F, Baston-Rey I, de la Iglesia-Garcia D, Calvino-Suarez C, et al
    Bismuth-containing quadruple therapy versus concomitant quadruple therapy as first-line treatment for Helicobacter Pylori infection in an area of high resistance to clarithromycin: A prospective, cross-sectional, comparative, open trial.
    Helicobacter. 2018 Oct 22:e12546. doi: 10.1111/hel.12546.
    PubMed     Text format     Abstract available


  36. DEKHNICH N, Ivanchik N, Kozlov R, Alimov A, et al
    Dynamics of antimicrobial resistance of Helicobacter pylori isolates in the Smolensk region of Russian Federation.
    Helicobacter. 2018 Oct 16:e12545. doi: 10.1111/hel.12545.
    PubMed     Text format     Abstract available


  37. CHAUHAN N, Tay ACY, Marshall BJ, Jain U, et al
    Helicobacter pylori VacA, a distinct toxin exerts diverse functionalities in numerous cells: An overview.
    Helicobacter. 2018 Oct 16:e12544. doi: 10.1111/hel.12544.
    PubMed     Text format     Abstract available


  38. MURATA M, Sugimoto M, Otsuka T, Nishida A, et al
    Successful Helicobacter pylori eradication therapy improves symptoms of chronic constipation.
    Helicobacter. 2018 Oct 15:e12543. doi: 10.1111/hel.12543.
    PubMed     Text format     Abstract available


  39. GOTODA T, Takano C, Kusano C, Suzuki S, et al
    Gut microbiome can be restored without adverse events after Helicobacter pylori eradication therapy in teenagers.
    Helicobacter. 2018 Oct 12:e12541. doi: 10.1111/hel.12541.
    PubMed     Text format     Abstract available


  40. ALI B, Chloe W, Mehmet A, Sofie B, et al
    Presence of gastric Helicobacter species in children suffering from gastric disorders in Southern Turkey.
    Helicobacter. 2018;23:e12511.
    PubMed     Text format     Abstract available


    September 2018
  41. EROSS B, Tinusz B, Farkas N, Hegyi P, et al
    Does Helicobacter pylori infection increase the risk of Barrett's esophagus and esophageal adenocarcinoma?
    Helicobacter. 2018 Sep 24:e12539. doi: 10.1111/hel.12539.
    PubMed     Text format    


  42. ABDEL-RAZIK A, Mousa N, Shabana W, Refaey M, et al
    Helicobacter pylori and non-alcoholic fatty liver disease: A new enigma?
    Helicobacter. 2018 Sep 23:e12537. doi: 10.1111/hel.12537.
    PubMed     Text format     Abstract available


  43. KRZYSIEK-MACZKA G, Targosz A, Szczyrk U, Strzalka M, et al
    Role of Helicobacter pylori infection in cancer-associated fibroblast-induced epithelial-mesenchymal transition in vitro.
    Helicobacter. 2018 Sep 23:e12538. doi: 10.1111/hel.12538.
    PubMed     Text format     Abstract available


  44. FEDER R, Posner S, Qin Y, Zheng J, et al
    Helicobacter pylori-associated peptic ulcer disease: A retrospective analysis of post-treatment testing practices.
    Helicobacter. 2018 Sep 23:e12540. doi: 10.1111/hel.12540.
    PubMed     Text format     Abstract available


  45. SIAVOSHI F, Saniee P, Malekzadeh R
    Effective antimicrobial activity of rifabutin against multidrug-resistant Helicobacter pylori.
    Helicobacter. 2018 Sep 19:e12531. doi: 10.1111/hel.12531.
    PubMed     Text format     Abstract available


  46. DOULBERIS M, Kountouras J, Polyzos SA, Tzivras D, et al
    Impact of Helicobacter pylori and/or Helicobacter pylori-related metabolic syndrome on gastroesophageal reflux disease- Barrett's esophagus- esophageal adenocarcinoma sequence.
    Helicobacter. 2018 Sep 12:e12534. doi: 10.1111/hel.12534.
    PubMed     Text format    


  47. LUO S, Liu W, Zeng Z, Ye F, et al
    Toxic adjuvants alter the function and phenotype of dendritic cells to initiate adaptive immune responses induced by oral Helicobacter pylori vaccines.
    Helicobacter. 2018 Sep 11:e12536. doi: 10.1111/hel.12536.
    PubMed     Text format     Abstract available


  48. YANG-OU YB, Hu Y, Zhu Y, Lu NH, et al
    The effect of antioxidants on Helicobacter pylori eradication: A systematic review with meta-analysis.
    Helicobacter. 2018 Sep 6:e12535. doi: 10.1111/hel.12535.
    PubMed     Text format     Abstract available


  49. HU Y, He C, Liu JP, Li NS, et al
    Analysis of key genes and signaling pathways involved in Helicobacter pylori-associated gastric cancer based on The Cancer Genome Atlas database and RNA sequencing data.
    Helicobacter. 2018 Sep 2:e12530. doi: 10.1111/hel.12530.
    PubMed     Text format     Abstract available


  50. KORI M, Daugule I, Urbonas V
    Helicobacter pylori and some aspects of gut microbiota in children.
    Helicobacter. 2018;23 Suppl 1:e12524.
    PubMed     Text format     Abstract available


  51. RAZUKA-EBELA D, Giupponi B, Franceschi F
    Helicobacter pylori and extragastric diseases.
    Helicobacter. 2018;23 Suppl 1:e12520.
    PubMed     Text format     Abstract available


  52. SJOMINA O, Pavlova J, Niv Y, Leja M, et al
    Epidemiology of Helicobacter pylori infection.
    Helicobacter. 2018;23 Suppl 1:e12514.
    PubMed     Text format     Abstract available


  53. O'MORAIN NR, Dore MP, O'Connor AJP, Gisbert JP, et al
    Treatment of Helicobacter pylori infection in 2018.
    Helicobacter. 2018;23 Suppl 1:e12519.
    PubMed     Text format     Abstract available


  54. SKREBINSKA S, Megraud F, Bessede E
    Diagnosis of Helicobacter pylori infection.
    Helicobacter. 2018;23 Suppl 1:e12515.
    PubMed     Text format     Abstract available


  55. JONAITIS L, Pellicano R, Kupcinskas L
    Helicobacter pylori and nonmalignant upper gastrointestinal diseases.
    Helicobacter. 2018;23 Suppl 1:e12522.
    PubMed     Text format     Abstract available


  56. WASKITO LA, Salama NR, Yamaoka Y
    Pathogenesis of Helicobacter pylori infection.
    Helicobacter. 2018;23 Suppl 1:e12516.
    PubMed     Text format     Abstract available


    August 2018
  57. CHENG HC, Liou JM, Luo JC, Chiu CT, et al
    The implementation of the consensus on the management of Helicobacter pylori and barriers to consensus.
    Helicobacter. 2018 Aug 29:e12533. doi: 10.1111/hel.12533.
    PubMed     Text format     Abstract available


  58. BENEJAT L, Ducournau A, Lehours P, Megraud F, et al
    Real-time PCR for Helicobacter pylori diagnosis. The best tools available.
    Helicobacter. 2018 Aug 28:e12512. doi: 10.1111/hel.12512.
    PubMed     Text format     Abstract available


  59. LI Z, Ying X, Shan F, Ji J, et al
    The association of garlic with Helicobacter pylori infection and gastric cancer risk: A systematic review and meta-analysis.
    Helicobacter. 2018 Aug 28:e12532. doi: 10.1111/hel.12532.
    PubMed     Text format     Abstract available


  60. MCNICHOLL AG, Molina-Infante J, Lucendo AJ, Calleja JL, et al
    Probiotic supplementation with Lactobacillus plantarum and Pediococcus acidilactici for Helicobacter pylori therapy: A randomized, double-blind, placebo-controlled trial.
    Helicobacter. 2018 Aug 23:e12529. doi: 10.1111/hel.12529.
    PubMed     Text format     Abstract available


  61. SILVA GM, Silva HM, Nascimento J, Goncalves JP, et al
    Helicobacter pylori antimicrobial resistance in a pediatric population.
    Helicobacter. 2018 Aug 9:e12528. doi: 10.1111/hel.12528.
    PubMed     Text format     Abstract available


    July 2018
  62. XIE Y, Zhang Z, Hong J, Liu W, et al
    Furazolidone-containing triple and quadruple eradication therapy for initial treatment for Helicobacter pylori infection: A multicenter randomized controlled trial in China.
    Helicobacter. 2018 Jul 22:e12496. doi: 10.1111/hel.12496.
    PubMed     Text format     Abstract available


    June 2018
  63. BASSAGH A, Hayatbakhsh Abasi M, Larussa T, Ghazizadeh M, et al
    Diminished circulating concentration of interleukin-35 in Helicobacter pylori-infected patients with peptic ulcer: Its association with FOXP3 gene polymorphism, bacterial virulence factor CagA, and gender of patients.
    Helicobacter. 2018 Jun 25:e12501. doi: 10.1111/hel.12501.
    PubMed     Text format     Abstract available


  64. EROSS B, Farkas N, Vincze A, Tinusz B, et al
    Helicobacter pylori infection reduces the risk of Barrett's esophagus: A meta-analysis and systematic review.
    Helicobacter. 2018 Jun 25:e12504. doi: 10.1111/hel.12504.
    PubMed     Text format     Abstract available


  65. SAKITANI K, Nishizawa T, Arita M, Yoshida S, et al
    Early detection of gastric cancer after Helicobacter pylori eradication due to endoscopic surveillance.
    Helicobacter. 2018 Jun 20:e12503. doi: 10.1111/hel.12503.
    PubMed     Text format     Abstract available


  66. ZAGARI RM, Romiti A, Ierardi E, Gravina AG, et al
    The "three-in-one" formulation of bismuth quadruple therapy for Helicobacter pylori eradication with or without probiotics supplementation: Efficacy and safety in daily clinical practice.
    Helicobacter. 2018 Jun 20:e12502. doi: 10.1111/hel.12502.
    PubMed     Text format     Abstract available


  67. LOPO I, Libanio D, Pita I, Dinis-Ribeiro M, et al
    Helicobacter pylori antibiotic resistance in Portugal: Systematic review and meta-analysis.
    Helicobacter. 2018 Jun 17:e12493. doi: 10.1111/hel.12493.
    PubMed     Text format     Abstract available


  68. HSU PI, Pan CY, Kao JY, Tsay FW, et al
    Helicobacter pylori eradication with bismuth quadruple therapy leads to dysbiosis of gut microbiota with an increased relative abundance of Proteobacteria and decreased relative abundances of Bacteroidetes and Actinobacteria.
    Helicobacter. 2018 Jun 13:e12498. doi: 10.1111/hel.12498.
    PubMed     Text format     Abstract available


  69. ROBOTIS J, Tsiodras S, Rokkas T
    Helicobacter pylori eradication may successfully treat primary cutaneous follicle center lymphoma.
    Helicobacter. 2018 Jun 13:e12499. doi: 10.1111/hel.12499.
    PubMed     Text format    


  70. GANTUYA B, Bolor D, Oyuntsetseg K, Erdene-Ochir Y, et al
    New observations regarding Helicobacter pylori and gastric cancer in Mongolia.
    Helicobacter. 2018 Jun 8:e12491. doi: 10.1111/hel.12491.
    PubMed     Text format     Abstract available


  71. UNLUSOY AKSU A, Yilmaz G, Egritas Gurkan O, Sari S, et al
    The effect of Helicobacter pylori eradication on functional dyspepsia in Turkish children.
    Helicobacter. 2018 Jun 6:e12497. doi: 10.1111/hel.12497.
    PubMed     Text format     Abstract available


  72. LI M, Oshima T, Horikawa T, Tozawa K, et al
    Systematic review with meta-analysis: Vonoprazan, a potent acid blocker, is superior to proton-pump inhibitors for eradication of clarithromycin-resistant strains of Helicobacter pylori.
    Helicobacter. 2018 Jun 6:e12495. doi: 10.1111/hel.12495.
    PubMed     Text format     Abstract available


  73. BLUMEL B, Goelz H, Kist M, Glocker EO, et al
    Retrospective study on outcome of salvage Helicobacter pylori eradication therapies based on molecular genetic susceptibility testing.
    Helicobacter. 2018 Jun 6:e12494. doi: 10.1111/hel.12494.
    PubMed     Text format     Abstract available


  74. RAMADAN M
    Eradication of Helicobacter pylori infection was associated with complete cure of resistant bleeding per gums.
    Helicobacter. 2018 Jun 5:e12492. doi: 10.1111/hel.12492.
    PubMed     Text format    


    May 2018
  75. SABERI S, Pournasr B, Farzaneh Z, Esmaeili M, et al
    A simple and cost-efficient adherent culture platform for human gastric primary cells, as an in vitro model for Helicobacter pylori infection.
    Helicobacter. 2018 May 17:e12489. doi: 10.1111/hel.12489.
    PubMed     Text format     Abstract available


    April 2018
  76. LONG X, Chen Q, Yu L, Liang X, et al
    Bismuth improves efficacy of proton-pump inhibitor clarithromycin, metronidazole triple Helicobacter pylori therapy despite a high prevalence of antimicrobial resistance.
    Helicobacter. 2018 Apr 25:e12485. doi: 10.1111/hel.12485.
    PubMed     Text format     Abstract available


  77. SAGHIER S, Schwarz SM, Anderson V, Gupta R, et al
    Pediatric Helicobacter pylori gastropathy demonstrates a unique pattern of gastric foveolar hyperplasia.
    Helicobacter. 2018 Apr 25:e12487. doi: 10.1111/hel.12487.
    PubMed     Text format     Abstract available


  78. MARCUS EA, Sachs G, Scott DR
    Acid-regulated gene expression of Helicobacter pylori: Insight into acid protection and gastric colonization.
    Helicobacter. 2018 Apr 25:e12490. doi: 10.1111/hel.12490.
    PubMed     Text format     Abstract available


  79. MUNOZ N, Sanchez-Delgado J, Baylina M, Puig I, et al
    Systematic review, meta-analysis, and meta-regression: Successful second-line treatment for Helicobacter pylori.
    Helicobacter. 2018 Apr 16:e12488. doi: 10.1111/hel.12488.
    PubMed     Text format     Abstract available


  80. YANG TT, Cao N, Zhang HH, Wei JB, et al
    Helicobacter pylori infection-induced H3Ser10 phosphorylation in stepwise gastric carcinogenesis and its clinical implications.
    Helicobacter. 2018 Apr 15:e12486. doi: 10.1111/hel.12486.
    PubMed     Text format     Abstract available


  81. KIM TJ, Kim ER, Chang DK, Kim YH, et al
    Age and gender may be the key points in hyperglycemic patients with Helicobacter pylori infection combined colorectal adenoma-author's reply.
    Helicobacter. 2018 Apr 11:e12484. doi: 10.1111/hel.12484.
    PubMed     Text format    


  82. VENNEMAN K, Huybrechts I, Gunter MJ, Vandendaele L, et al
    The epidemiology of Helicobacter pylori infection in Europe and the impact of lifestyle on its natural evolution toward stomach cancer after infection: A systematic review.
    Helicobacter. 2018 Apr 10:e12483. doi: 10.1111/hel.12483.
    PubMed     Text format     Abstract available


    March 2018
  83. PARK H, Park JJ, Park YM, Baik SJ, et al
    The association between Helicobacter pylori infection and the risk of advanced colorectal neoplasia may differ according to age and cigarette smoking.
    Helicobacter. 2018 Mar 29:e12477. doi: 10.1111/hel.12477.
    PubMed     Text format     Abstract available


  84. CREMNITER J, Bodet C, Tougeron D, Dray X, et al
    Th-17 response and antimicrobial peptide expression are uniformly expressed in gastric mucosa of Helicobacter pylori-infected patients independently of their clinical outcomes.
    Helicobacter. 2018 Mar 27:e12479. doi: 10.1111/hel.12479.
    PubMed     Text format     Abstract available


  85. MIERNYK KM, Bulkow LR, Gold BD, Bruce MG, et al
    Prevalence of Helicobacter pylori among Alaskans: Factors associated with infection and comparison of urea breath test and anti-Helicobacter pylori IgG antibodies.
    Helicobacter. 2018 Mar 14. doi: 10.1111/hel.12482.
    PubMed     Text format     Abstract available


  86. SHU X, Yin G, Liu M, Peng K, et al
    Antibiotics resistance of Helicobacter pylori in children with upper gastrointestinal symptoms in Hangzhou, China.
    Helicobacter. 2018 Mar 12. doi: 10.1111/hel.12481.
    PubMed     Text format     Abstract available


  87. KIM JH, Lee SY, Lee SP, Kim JH, et al
    The histologic detection of Helicobacter pylori in seropositive subjects is affected by pathology and secretory ability of the stomach.
    Helicobacter. 2018 Mar 8. doi: 10.1111/hel.12480.
    PubMed     Text format     Abstract available


  88. YEN CH, Chiu HF, Huang SY, Lu YY, et al
    Beneficial effect of Burdock complex on asymptomatic Helicobacter pylori-infected subjects: A randomized, double-blind placebo-controlled clinical trial.
    Helicobacter. 2018 Mar 8. doi: 10.1111/hel.12469.
    PubMed     Text format     Abstract available


  89. LIU WZ, Xie Y, Lu H, Cheng H, et al
    Fifth Chinese National Consensus Report on the management of Helicobacter pylori infection.
    Helicobacter. 2018 Mar 7. doi: 10.1111/hel.12475.
    PubMed     Text format     Abstract available


  90. SUGIZAKI K, Tari A, Kitadai Y, Oda I, et al
    Anti-Helicobacter pylori therapy in localized gastric mucosa-associated lymphoid tissue lymphoma: A prospective, nationwide, multicenter study in Japan.
    Helicobacter. 2018 Mar 4. doi: 10.1111/hel.12474.
    PubMed     Text format     Abstract available


  91. OPEKUN AR, Gonzales SA, Al-Saadi MA, Graham DY, et al
    Brief report: Lactobacillus bulgaricus GLB44 (Proviotic() ) plus esomeprazole for Helicobacter pylori eradication: A pilot study.
    Helicobacter. 2018 Mar 4. doi: 10.1111/hel.12476.
    PubMed     Text format     Abstract available


  92. LEE YC, Asaka M, Graham DY
    Helicobacter pylori and gastric cancer in Alaskan Natives: Time to stop studyingH. pylori and to eradicate it.
    Helicobacter. 2018 Mar 2. doi: 10.1111/hel.12478.
    PubMed     Text format    


    February 2018
  93. OHISHI T, Masuda T, Abe H, Hayashi C, et al
    Monotherapy with a novel intervenolin derivative, AS-1934, is an effective treatment for Helicobacter pylori infection.
    Helicobacter. 2018 Feb 28. doi: 10.1111/hel.12470.
    PubMed     Text format     Abstract available


  94. TALARICO S, Korson AS, Leverich CK, Park S, et al
    High prevalence of Helicobacter pylori clarithromycin resistance mutations among Seattle patients measured by droplet digital PCR.
    Helicobacter. 2018 Feb 26. doi: 10.1111/hel.12472.
    PubMed     Text format     Abstract available


  95. KUO YC, Shih SC, Yu LY, Wu MS, et al
    Age and gender may be the key points in hyperglycemic patients with Helicobacter pylori infection combined colorectal adenoma.
    Helicobacter. 2018 Feb 26. doi: 10.1111/hel.12473.
    PubMed     Text format    


  96. ZHUGE L, Wang Y, Wu S, Zhao RL, et al
    Furazolidone treatment for Helicobacter Pylori infection: A systematic review and meta-analysis.
    Helicobacter. 2018 Feb 26. doi: 10.1111/hel.12468.
    PubMed     Text format     Abstract available


  97. SIAVOSHI F, Sahraee M, Ebrahimi H, Sarrafnejad A, et al
    Natural fruits, flowers, honey, and honeybees harbor Helicobacter pylori-positive yeasts.
    Helicobacter. 2018 Feb 19. doi: 10.1111/hel.12471.
    PubMed     Text format     Abstract available


  98. WANG YH, Li Z, Wang L, Zhu-Ge LY, et al
    A systematic review and meta-analysis of genotypic methods for detecting antibiotic resistance in Helicobacter pylori.
    Helicobacter. 2018 Feb 6. doi: 10.1111/hel.12467.
    PubMed     Text format     Abstract available


    January 2018
  99. CHOE JW, Jung SW, Kim SY, Hyun JJ, et al
    Comparative study of Helicobacter pylori eradication rates of concomitant therapy vs modified quadruple therapy comprising proton-pump inhibitor, bismuth, amoxicillin, and metronidazole in Korea.
    Helicobacter. 2018 Jan 25. doi: 10.1111/hel.12466.
    PubMed     Text format     Abstract available


  100. BAE SE, Choi KD, Choe J, Kim SO, et al
    The effect of eradication of Helicobacter pylori on gastric cancer prevention in healthy asymptomatic populations.
    Helicobacter. 2018 Jan 18. doi: 10.1111/hel.12464.
    PubMed     Text format     Abstract available


  101. DORE MP, Salis R, Loria MF, Villanacci V, et al
    Helicobacter pylori infection and occurrence of celiac disease in subjects HLA-DQ2/DQ8 positive: A prospective study.
    Helicobacter. 2018 Jan 18. doi: 10.1111/hel.12465.
    PubMed     Text format     Abstract available


  102. LEE JH, Choi KD, Jung HY, Baik GH, et al
    Seroprevalence of Helicobacter pylori in Korea: A multicenter, nationwide study conducted in 2015 and 2016.
    Helicobacter. 2018 Jan 18. doi: 10.1111/hel.12463.
    PubMed     Text format     Abstract available


  103. BOEHNKE KF, Brewster RK, Sanchez BN, Valdivieso M, et al
    An assessment of drinking water contamination with Helicobacter pylori in Lima, Peru.
    Helicobacter. 2018 Jan 8. doi: 10.1111/hel.12462.
    PubMed     Text format     Abstract available


  104. WANG YK, Chiang WC, Kuo FC, Wu MC, et al
    Levels of malondialdehyde in the gastric juice: Its association with Helicobacter pylori infection and stomach diseases.
    Helicobacter. 2018 Jan 5. doi: 10.1111/hel.12460.
    PubMed     Text format     Abstract available


    December 2017
  105. SUE S, Ogushi M, Arima I, Kuwashima H, et al
    Vonoprazan- vs proton-pump inhibitor-based first-line 7-day triple therapy for clarithromycin-susceptible Helicobacter pylori: A multicenter, prospective, randomized trial.
    Helicobacter. 2017 Dec 21. doi: 10.1111/hel.12456.
    PubMed     Text format     Abstract available


  106. CEN L, Pan J, Zhou B, Yu C, et al
    Helicobacter Pylori infection of the gallbladder and the risk of chronic cholecystitis and cholelithiasis: A systematic review and meta-analysis.
    Helicobacter. 2017 Dec 20. doi: 10.1111/hel.12457.
    PubMed     Text format     Abstract available


  107. STENT A, Every AL, Chionh YT, Ng GZ, et al
    Superoxide dismutase from Helicobacter pylori suppresses the production of pro-inflammatory cytokines during in vivo infection.
    Helicobacter. 2017 Dec 13. doi: 10.1111/hel.12459.
    PubMed     Text format     Abstract available


  108. GONZALEZ-PONS M, Soto-Salgado M, Sevilla J, Marquez-Lespier JM, et al
    Seroprevalence of Helicobacter pylori in Hispanics living in Puerto Rico: A population-based study.
    Helicobacter. 2017 Dec 6. doi: 10.1111/hel.12453.
    PubMed     Text format     Abstract available


    November 2017
  109. DOULBERIS M, Kotronis G, Thomann R, Polyzos SA, et al
    Impact of Helicobacter pylori on Alzheimer's disease: What do we know so far?
    Helicobacter. 2017 Nov 27. doi: 10.1111/hel.12454.
    PubMed     Text format     Abstract available


  110. BEER-DAVIDSON G, Hindiyeh M, Muhsen K
    Detection of Helicobacter pylori in stool samples of young children using real-time polymerase chain reaction.
    Helicobacter. 2017 Nov 27. doi: 10.1111/hel.12450.
    PubMed     Text format     Abstract available


  111. MUNOZ-GOMEZ P, Jordan-Castro JA, Abanades-Tercero M, Blanco-Gonzalez JJ, et al
    Macrolide use in the previous years is associated with failure to eradicate Helicobacter pylori with clarithromycin-containing regimens.
    Helicobacter. 2017 Nov 26. doi: 10.1111/hel.12452.
    PubMed     Text format     Abstract available


  112. NG QX, Venkatanarayanan N, De Deyn MLZQ, Ho CYX, et al
    A meta-analysis of the association between Helicobacter pylori (H. pylori) infection and hyperemesis gravidarum.
    Helicobacter. 2017 Nov 26. doi: 10.1111/hel.12455.
    PubMed     Text format     Abstract available


  113. HAYS C, Burucoa C, Lehours P, Tran CT, et al
    Molecular characterization of Helicobacter pylori resistance to rifamycins.
    Helicobacter. 2017 Nov 23. doi: 10.1111/hel.12451.
    PubMed     Text format     Abstract available


  114. KAWAKUBO M, Horiuchi K, Matsumoto T, Nakayama J, et al
    Cholesterol-alpha-glucosyltransferase gene is present in most Helicobacter species including gastric non-Helicobacter pylori helicobacters obtained from Japanese patients.
    Helicobacter. 2017 Nov 7. doi: 10.1111/hel.12449.
    PubMed     Text format     Abstract available


  115. FIORINI G, Saracino IM, Zullo A, Gatta L, et al
    Rescue therapy with bismuth quadruple regimen in patients with Helicobacter pylori -resistant strains.
    Helicobacter. 2017 Nov 1. doi: 10.1111/hel.12448.
    PubMed     Text format     Abstract available


    October 2017
  116. PASTUKH N, Binyamin D, On A, Paritsky M, et al
    GenoType(R) HelicoDR test in comparison with histology and culture for Helicobacter pylori detection and identification of resistance mutations to clarithromycin and fluoroquinolones.
    Helicobacter. 2017 Oct 23. doi: 10.1111/hel.12447.
    PubMed     Text format     Abstract available


  117. RAAF N, Amhis W, Saoula H, Abid A, et al
    Prevalence, antibiotic resistance, and MLST typing of Helicobacter pylori in Algiers, Algeria.
    Helicobacter. 2017 Oct 16. doi: 10.1111/hel.12446.
    PubMed     Text format     Abstract available


  118. TAKEOKA A, Tayama J, Kobayashi M, Sagara I, et al
    Psychological effects of Helicobacter pylori-associated atrophic gastritis in patients under 50 years: A cross-sectional study.
    Helicobacter. 2017 Oct 16. doi: 10.1111/hel.12445.
    PubMed     Text format     Abstract available


  119. ATILGAN CU, Kosekahya P, Yozgat A, Sen E, et al
    Are optic nerve heads of patients with helicobacter pylori infection more susceptible to glaucomatous damage?
    Helicobacter. 2017 Oct 5. doi: 10.1111/hel.12443.
    PubMed     Text format     Abstract available


    September 2017
  120. KHADANGI F, Yassi M, Kerachian MA
    Diagnostic accuracy of PCR-based detection tests for Helicobacter Pylori in stool samples: A systematic review and meta-analysis.
    Helicobacter. 2017 Sep 29. doi: 10.1111/hel.12444.
    PubMed     Text format     Abstract available


  121. WANGDA S, Richter JM, Kuenzang P, Wangchuk K, et al
    Epidemiology of Helicobacter pylori infection in asymptomatic schoolchildren in Bhutan.
    Helicobacter. 2017 Sep 22. doi: 10.1111/hel.12439.
    PubMed     Text format     Abstract available


  122. KIM SY, Lee SW, Choe JW, Jung SW, et al
    Helicobacter pylori eradication rates of concomitant and sequential therapies in Korea.
    Helicobacter. 2017 Sep 21. doi: 10.1111/hel.12441.
    PubMed     Text format     Abstract available


  123. MACIAS-GARCIA F, Llovo-Taboada J, Diaz-Lopez M, Baston-Rey I, et al
    High primary antibiotic resistance of Helicobacter Pylori strains isolated from dyspeptic patients: A prevalence cross-sectional study in Spain.
    Helicobacter. 2017 Sep 15. doi: 10.1111/hel.12440.
    PubMed     Text format     Abstract available


  124. DONG SQ, Singh TP, Wei X, Yao H, et al
    A Japanese population-based meta-analysis of vonoprazan versus PPI for Helicobacter pylori eradication therapy: Is superiority an illusion?
    Helicobacter. 2017 Sep 8. doi: 10.1111/hel.12438.
    PubMed     Text format     Abstract available


  125. KALACH N, Bontems P, Raymond J
    Helicobacter pylori infection in children.
    Helicobacter. 2017;22 Suppl 1.
    PubMed     Text format     Abstract available


  126. BURUCOA C, Axon A
    Epidemiology of Helicobacter pylori infection.
    Helicobacter. 2017;22 Suppl 1.
    PubMed     Text format     Abstract available


  127. O'CONNOR A, Lamarque D, Gisbert JP, O'Morain C, et al
    Treatment of Helicobacter pylori infection 2017.
    Helicobacter. 2017;22 Suppl 1.
    PubMed     Text format     Abstract available


  128. SJOMINA O, Heluwaert F, Moussata D, Leja M, et al
    Helicobacter pylori infection and nonmalignant diseases.
    Helicobacter. 2017;22 Suppl 1.
    PubMed     Text format     Abstract available


  129. BESSEDE E, Arantes V, Megraud F, Coelho LG, et al
    Diagnosis of Helicobacter pylori infection.
    Helicobacter. 2017;22 Suppl 1.
    PubMed     Text format     Abstract available


  130. DE KORWIN JD, Ianiro G, Gibiino G, Gasbarrini A, et al
    Helicobacter pylori infection and extragastric diseases in 2017.
    Helicobacter. 2017;22 Suppl 1.
    PubMed     Text format     Abstract available


  131. THORELL K, Lehours P, Vale FF
    Genomics of Helicobacter pylori.
    Helicobacter. 2017;22 Suppl 1.
    PubMed     Text format     Abstract available


  132. CAMILO V, Sugiyama T, Touati E
    Pathogenesis of Helicobacter pylori infection.
    Helicobacter. 2017;22 Suppl 1.
    PubMed     Text format     Abstract available


  133. VENERITO M, Vasapolli R, Rokkas T, Delchier JC, et al
    Helicobacter pylori, gastric cancer and other gastrointestinal malignancies.
    Helicobacter. 2017;22 Suppl 1.
    PubMed     Text format     Abstract available


    August 2017
  134. GUO L, Yin R, Xu G, Gong X, et al
    Immunologic properties and therapeutic efficacy of a multivalent epitope-based vaccine against four Helicobacter pylori adhesins (urease, Lpp20, HpaA, and CagL) in Mongolian gerbils.
    Helicobacter. 2017 Aug 29. doi: 10.1111/hel.12428.
    PubMed     Text format     Abstract available


  135. KWON YH, Kim JY, Kim N, Park JH, et al
    Specific mutations of penicillin-binding protein 1A in 77 clinically acquired amoxicillin-resistant Helicobacter pylori strains in comparison with 77 amoxicillin-susceptible strains.
    Helicobacter. 2017 Aug 25. doi: 10.1111/hel.12437.
    PubMed     Text format     Abstract available


  136. MIEHLKE S, Frederking D, Gunther T, Glocker E, et al
    Efficacy of three-in-one capsule bismuth quadruple therapy for Helicobacter pylori eradication in clinical practice in a multinational patient population.
    Helicobacter. 2017 Aug 22. doi: 10.1111/hel.12429.
    PubMed     Text format     Abstract available


  137. CHOI SH, Kim DM, Lee J, Yun NR, et al
    Endoscopic characteristics of infection-associated peptic ulcers.
    Helicobacter. 2017 Aug 18. doi: 10.1111/hel.12427.
    PubMed     Text format     Abstract available


  138. LIU W, Tan Z, Liu H, Zeng Z, et al
    Nongenetically modified Lactococcus lactis-adjuvanted vaccination enhanced innate immunity against Helicobacter pylori.
    Helicobacter. 2017 Aug 14. doi: 10.1111/hel.12426.
    PubMed     Text format     Abstract available


  139. GINESTET F, Guibourg B, Doucet L, Thereaux J, et al
    Upfront immunohistochemistry improves specificity of Helicobacter pylori diagnosis. A French pathology laboratory point of view.
    Helicobacter. 2017 Aug 11. doi: 10.1111/hel.12424.
    PubMed     Text format     Abstract available


  140. TSUDA M, Asaka M, Kato M, Matsushima R, et al
    Effect on Helicobacter pylori eradication therapy against gastric cancer in Japan.
    Helicobacter. 2017 Aug 3. doi: 10.1111/hel.12415.
    PubMed     Text format     Abstract available


  141. RODRIGUEZ DE SANTIAGO E, Martin de Argila de Prados C, Marcos Prieto HM, Jorge Turrion MA, et al
    Limited effectiveness with a 10-day bismuth-containing quadruple therapy (Pylera(R) ) in third-line recue treatment for Helicobacter pylori infection. A real-life multicenter study.
    Helicobacter. 2017 Aug 3. doi: 10.1111/hel.12423.
    PubMed     Text format     Abstract available


  142. ZHOU X, Su J, Zhu L, Zhang G, et al
    Helicobacter pylori modulates cisplatin sensitivity in gastric cancer by down-regulating miR-141 expression.
    Helicobacter. 2017;22.
    PubMed     Text format    


    July 2017
  143. FERNANDEZ-DE-LARREA N, Michel A, Romero B, Butt J, et al
    Antibody reactivity against Helicobacter pylori proteins in a sample of the Spanish adult population in 2008-2013.
    Helicobacter. 2017 Jul 24. doi: 10.1111/hel.12401.
    PubMed     Text format     Abstract available


    June 2017
  144. BUTENKO T, Jeverica S, Orel R, Homan M, et al
    Antibacterial resistance and the success of tailored triple therapy in Helicobacter pylori strains isolated from Slovenian children.
    Helicobacter. 2017 Jun 27. doi: 10.1111/hel.12400.
    PubMed     Text format     Abstract available


  145. ZABALA TORRRES B, Lucero Y, Lagomarcino AJ, Orellana-Manzano A, et al
    Prevalence and dynamics of Helicobacter pylori infection during childhood.
    Helicobacter. 2017 Jun 23. doi: 10.1111/hel.12399.
    PubMed     Text format     Abstract available


  146. SHEN X, Yang H, Wu Y, Zhang D, et al
    Association of Helicobacter pylori infection with Parkinson's diseases: A meta-analysis.
    Helicobacter. 2017 Jun 9. doi: 10.1111/hel.12398.
    PubMed     Text format     Abstract available


    May 2017
  147. OSAKI T, Mabe K, Zaman C, Yonezawa H, et al
    Usefulness of detection of clarithromycin-resistant Helicobacter pylori from fecal specimens for young adults treated with eradication therapy.
    Helicobacter. 2017 May 22. doi: 10.1111/hel.12396.
    PubMed     Text format     Abstract available


  148. SECKA O, Vale FF, Buissonniere A, Thomas JE, et al
    Phylogeographic agreement between prophage and bacterial housekeeping genes in Helicobacter pylori strains from The Gambia.
    Helicobacter. 2017 May 22. doi: 10.1111/hel.12394.
    PubMed     Text format    


  149. SHEHATA MA, Talaat R, Soliman S, Elmesseri H, et al
    Randomized controlled study of a novel triple nitazoxanide (NTZ)-containing therapeutic regimen versus the traditional regimen for eradication of Helicobacter pylori infection.
    Helicobacter. 2017 May 19. doi: 10.1111/hel.12395.
    PubMed     Text format     Abstract available


    April 2017
  150. BOEHNKE KF, Eaton KA, Fontaine C, Brewster R, et al
    Reduced infectivity of waterborne viable but nonculturable Helicobacter pylori strain SS1 in mice.
    Helicobacter. 2017 Apr 24. doi: 10.1111/hel.12391.
    PubMed     Text format     Abstract available


  151. SILVA B, Nunes A, Vale FF, Rocha R, et al
    The expression of Helicobacter pylori tfs plasticity zone cluster is regulated by pH and adherence, and its composition is associated with differential gastric IL-8 secretion.
    Helicobacter. 2017 Apr 24. doi: 10.1111/hel.12390.
    PubMed     Text format     Abstract available


  152. JUNG YS, Park CH, Park JH, Nam E, et al
    Efficacy of Helicobacter pylori eradication therapies in Korea: A systematic review and network meta-analysis.
    Helicobacter. 2017 Apr 19. doi: 10.1111/hel.12389.
    PubMed     Text format     Abstract available


  153. KOCSMAR E, Szirtes I, Kramer Z, Szijarto A, et al
    Sensitivity of Helicobacter pylori detection by Giemsa staining is poor in comparison with immunohistochemistry and fluorescent in situ hybridization and strongly depends on inflammatory activity.
    Helicobacter. 2017 Apr 12. doi: 10.1111/hel.12387.
    PubMed     Text format     Abstract available


  154. ANSARI S, Yamaoka Y
    Survival of Helicobacter pylori in gastric acidic territory.
    Helicobacter. 2017 Apr 12. doi: 10.1111/hel.12386.
    PubMed     Text format     Abstract available


  155. LEE AY, Kao CY, Wang YK, Lin SY, et al
    Inactivation of ferric uptake regulator (Fur) attenuates Helicobacter pylori J99 motility by disturbing the flagellar motor switch and autoinducer-2 production.
    Helicobacter. 2017 Apr 12. doi: 10.1111/hel.12388.
    PubMed     Text format     Abstract available


  156. AL-SINANI S, Al-Mulaabed SW, Al-Naamani K, Al-Sharji H, et al
    Helicobacter Pylori infection in Omani children.
    Helicobacter. 2017;22.
    PubMed     Text format    


    March 2017
  157. CHENG HC, Tsai YC, Yang HB, Yeh YC, et al
    The corpus-predominant gastritis index can be an early and reversible marker to identify the gastric cancer risk of Helicobacter pylori-infected nonulcer dyspepsia.
    Helicobacter. 2017 Mar 22. doi: 10.1111/hel.12385.
    PubMed     Text format     Abstract available


  158. KOTILEA K, Mekhael J, Salame A, Mahler T, et al
    Eradication rate of Helicobacter Pylori infection is directly influenced by adherence to therapy in children.
    Helicobacter. 2017 Mar 17. doi: 10.1111/hel.12383.
    PubMed     Text format     Abstract available


  159. BARTELS LE, Jepsen P, Tottrup A, Vilstrup H, et al
    Helicobacter pylori infection is associated with reduced prevalence of colonic diverticular disease.
    Helicobacter. 2017 Mar 16. doi: 10.1111/hel.12384.
    PubMed     Text format     Abstract available


  160. OLEASTRO M, Rocha R, Vale FF
    Population genetic structure of Helicobacter pylori strains from Portuguese-speaking countries.
    Helicobacter. 2017 Mar 8. doi: 10.1111/hel.12382.
    PubMed     Text format     Abstract available


    February 2017
  161. CHUAH YY, Wu DC, Chuah SK, Yang JC, et al
    Real-world practice and Expectation of Asia-Pacific physicians and patients in Helicobacter Pylori eradication (REAP-HP Survey).
    Helicobacter. 2017 Feb 28. doi: 10.1111/hel.12380.
    PubMed     Text format     Abstract available


  162. ALVAREZ A, Toledo H
    The histone-like protein HU has a role in gene expression during the acid adaptation response in Helicobacter pylori.
    Helicobacter. 2017 Feb 28. doi: 10.1111/hel.12381.
    PubMed     Text format     Abstract available


  163. NG GZ, Ke BX, Laskowski A, Thorburn DR, et al
    No evidence of a role for mitochondrial complex I in Helicobacter pylori pathogenesis.
    Helicobacter. 2017 Feb 9. doi: 10.1111/hel.12378.
    PubMed     Text format     Abstract available


    January 2017
  164. TURSI A, Di Mario F, Franceschi M, De Bastiani R, et al
    New bismuth-containing quadruple therapy in patients infected with Helicobacter pylori: A first Italian experience in clinical practice.
    Helicobacter. 2017 Jan 26. doi: 10.1111/hel.12371.
    PubMed     Text format     Abstract available


  165. KIM TJ, Kim ER, Chang DK, Kim YH, et al
    Helicobacter pylori infection is an independent risk factor of early and advanced colorectal neoplasm.
    Helicobacter. 2017 Jan 26. doi: 10.1111/hel.12377.
    PubMed     Text format     Abstract available


  166. TANAKA S, Nagashima H, Uotani T, Graham DY, et al
    Autophagy-related genes in Helicobacter pylori infection.
    Helicobacter. 2017 Jan 23. doi: 10.1111/hel.12376.
    PubMed     Text format     Abstract available


  167. ONO S, Kato M, Nakagawa S, Mabe K, et al
    Vonoprazan improves the efficacy of Helicobacter pylori eradication therapy with a regimen consisting of clarithromycin and metronidazole in patients allergic to penicillin.
    Helicobacter. 2017 Jan 18. doi: 10.1111/hel.12374.
    PubMed     Text format     Abstract available


  168. MORAIS S, Costa AR, Ferro A, Lunet N, et al
    Contemporary migration patterns in the prevalence of Helicobacter pylori infection: A systematic review.
    Helicobacter. 2017 Jan 18. doi: 10.1111/hel.12372.
    PubMed     Text format     Abstract available


  169. LI L, Ke Y, Yu C, Li G, et al
    Antibiotic resistance of Helicobacter pylori in Chinese children: A multicenter retrospective study over 7 years.
    Helicobacter. 2017 Jan 18. doi: 10.1111/hel.12373.
    PubMed     Text format     Abstract available


  170. SHEU BS, Wu MS, Chiu CT, Lo JC, et al
    Consensus on the clinical management, screening-to-treat, and surveillance of Helicobacter pylori infection to improve gastric cancer control on a nationwide scale.
    Helicobacter. 2017 Jan 8. doi: 10.1111/hel.12368.
    PubMed     Text format     Abstract available


    December 2016
  171. SONNENBERG A, Dellon ES, Turner KO, Genta RM, et al
    The influence of Helicobacter pylori on the ethnic distribution of esophageal eosinophilia.
    Helicobacter. 2016 Dec 28. doi: 10.1111/hel.12370.
    PubMed     Text format     Abstract available


  172. SHAMSDIN SA, Alborzi A, Rasouli M, Ghaderi A, et al
    The importance of TH22 and TC22 cells in the pathogenesis of Helicobacter pylori-associated gastric diseases.
    Helicobacter. 2016 Dec 19. doi: 10.1111/hel.12367.
    PubMed     Text format     Abstract available


  173. SUN X, Zhang M, El-Zaatari M, Huffnagle GB, et al
    CCR2 mediates Helicobacter pylori-induced immune tolerance and contributes to mucosal homeostasis.
    Helicobacter. 2016 Dec 8. doi: 10.1111/hel.12366.
    PubMed     Text format     Abstract available


    November 2016
  174. FERENC S, Gnus J, Koscielna M, Kinda M, et al
    High antibiotic resistance of Helicobacter pylori and its effect on tailored and empiric eradication of the organism in Lower Silesia, Poland.
    Helicobacter. 2016 Nov 23. doi: 10.1111/hel.12365.
    PubMed     Text format     Abstract available


    October 2016
  175. DEN HOLLANDER WJ, Schalekamp-Timmermans S, Holster IL, Jaddoe VW, et al
    Helicobacter pylori colonization and pregnancies complicated by preeclampsia, spontaneous prematurity, and small for gestational age birth.
    Helicobacter. 2016 Oct 27. doi: 10.1111/hel.12364.
    PubMed     Text format     Abstract available


  176. NAKAYAMA Y, Lin Y, Hongo M, Hidaka H, et al
    Helicobacter pylori infection and its related factors in junior high school students in Nagano Prefecture, Japan.
    Helicobacter. 2016 Oct 27. doi: 10.1111/hel.12363.
    PubMed     Text format     Abstract available


  177. ZHOU L, Zhao F, Hu B, Fang Y, et al
    A Creative Helicobacter pylori Diagnosis Scheme Based on Multiple Genetic Analysis System: Qualification and Quantitation.
    Helicobacter. 2016;21:441.
    PubMed     Text format    


    September 2016
  178. MIHARA H, Suzuki N, Muhammad JS, Nanjo S, et al
    Transient receptor potential vanilloid 4 (TRPV4) silencing in Helicobacter pylori-infected human gastric epithelium.
    Helicobacter. 2016 Sep 30. doi: 10.1111/hel.12361.
    PubMed     Text format     Abstract available


  179. ABDUL RAHIM NR, Benson J, Grocke K, Vather D, et al
    Prevalence of Helicobacter pylori infection in newly arrived refugees attending the Migrant Health Service, South Australia.
    Helicobacter. 2016 Sep 22. doi: 10.1111/hel.12360.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Peptic Ulcer is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: